Calysta has appointed Thomas JG Huot, as its chief operating officer to lead global operations and corporate development activities. Additionally, Dr Huot is responsible for corporate strategy and the commercialization of Calysta’s FeedKind protein. He has been with Calysta since 2018 as its chief business officer.
Huot has over 20 years of experience in research in biological sciences, venture investing, project financing and strategic partnerships, including a significant focus on industrial biotechnology, specialty chemicals and nutrition.
Prior to joining Calysta, he had worked with VantagePoint Capital Partners, a global venture investor with a focus on energy innovation and technology that had more than $4bn under management, where he was a managing director, leading the industrial biotechnology, food and agtech investing practice.
Huot provided strategic advisory services to start-up companies and investment funds in the life sciences and nutrition sectors for Novalis Advisors LLC.